Pharmacology Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy: March 2012 A aPTT B CT C PT D Anti-factor Xa activity 💡 Explanation Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy: March 2012 ✓ Correct Answer: D. Anti-factor Xa activity